Cargando…
Aortic valve replacement in a patient with sickle cell disease—Are we justified to perform surgery in the TAVI era?
Not all variants of SCD need the same management and this should be decided on a case‐by‐case basis. Heterozygous SCD patients can undergo cardiac surgery without the need for intraoperative exchange transfusions with good clinical outcomes.
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8387662/ https://www.ncbi.nlm.nih.gov/pubmed/34471536 http://dx.doi.org/10.1002/ccr3.4085 |